Relay Therapeutics IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 19.45 USD | 20,79 USD | 3,025 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 26,077 USD | 6 | 5 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 217.940.332 | 22,76 | 9,47 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Relay Therapeutics Inc
Mitarbeiter 193
Handelsplatz NASDAQ
Ticker Symbol RLAY
IPO Datum 2020-07-16
Adresse 60 Hampshire Street, Cambridge, MA, United States, 02139
Webseite https://www.relaytx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS | CEO, President & Director |
| 2 | Dr. Mark Murcko Ph.D. | Founder & Independent Director |
| 3 | Mr. Thomas Catinazzo | Chief Financial Officer |
| 4 | Mr. Peter Rahmer | Chief Corporate Development Officer |
| 5 | Dr. Donald A. Bergstrom M.D., Ph.D. | President of Research & Development |
| 6 | Ms. Dorothee Kern Ph.D. | Founder |
| 7 | Dr. David Elliot Shaw Ph.D. | Founder |
| 8 | Dr. Matthew P. Jacobson Ph.D. | Founder |
| 9 | Mr. Jim Watters Ph.D. | Chief Scientific Officer |
| 10 | Ms. Soo-Yeun Lim J.D. | Senior VP & General Counsel |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | SB INVESTMENT ADVISERS (UK) LTD | 0,00% | 0,00 Mio. USD |
| 2 | COMMODORE CAPITAL LP | 0,00% | 0,00 Mio. USD |
| 3 | Casdin Capital, LLC | 0,00% | 0,00 Mio. USD |
| 4 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 5 | Perceptive Advisors LLC | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 7 | Bellevue Group AG | 0,00% | 0,00 Mio. USD |
| 8 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 10 | Nextech Invest, Ltd. | 0,00% | 0,00 Mio. USD |
| 11 | TCG Crossover Management, LLC | 0,00% | 0,00 Mio. USD |
| 12 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 13 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 14 | Balyasny Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 15 | Spruce Street Capital LP | 0,00% | 0,00 Mio. USD |
| 16 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 17 | Adage Capital Partners Gp LLC | 0,00% | 0,00 Mio. USD |
| 18 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 19 | MPM Oncology Impact Management LP | 0,00% | 0,00 Mio. USD |
| 20 | Bank of America Corp | 0,00% | 0,00 Mio. USD |